RGAEX
Price
$78.52
Change
-$9.47 (-10.76%)
Updated
Feb 3 closing price
Net Assets
335.97B
RWGFX
Price
$4.24
Change
-$0.66 (-13.47%)
Updated
Feb 3 closing price
Net Assets
28.48M
Interact to see
Advertisement

RGAEX vs RWGFX

Header iconRGAEX vs RWGFX Comparison
Open Charts RGAEX vs RWGFXBanner chart's image
American Funds Growth Fund of Amer R4
Price$78.52
Change-$9.47 (-10.76%)
VolumeN/A
Net Assets335.97B
Wedgewood Retail
Price$4.24
Change-$0.66 (-13.47%)
VolumeN/A
Net Assets28.48M
RGAEX vs RWGFX Comparison Chart in %
View a ticker or compare two or three
VS
RGAEX vs. RWGFX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGAEX is a Hold and RWGFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAEX has more cash in the bank: 336B vs. RWGFX (28.5M). RGAEX pays higher dividends than RWGFX: RGAEX (0.23) vs RWGFX (0.00). RGAEX was incepted earlier than RWGFX: RGAEX (24 years) vs RWGFX (15 years). RWGFX (1.32) is less costly to investors than RGAEX (0.63). RGAEX is a more actively managed with annual turnover of: 32.00 vs. RWGFX (23.00). RGAEX has a lower initial minimum investment than RWGFX: RGAEX (250) vs RWGFX (1000). RGAEX annual gain was more profitable for investors over the last year : 2.60 vs. RWGFX (-10.92). RGAEX return over 5 years is better than : 13.17 vs. RWGFX (-8.82).
RGAEXRWGFXRGAEX / RWGFX
Total Expense Ratio0.631.2550%
Annual Report Gross Expense Ratio0.631.3248%
Fund Existence24 years15 years-
Gain YTD-1.0210.474-215%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets336B28.5M1,178,947%
Annual Yield % from dividends0.230.00-
Returns for 1 year2.60-10.92-24%
Returns for 3 years44.5813.37333%
Returns for 5 years13.17-8.82-149%
Returns for 10 years118.85-71.45-166%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KYMR77.221.60
+2.12%
Kymera Therapeutics
BUD73.531.08
+1.49%
Anheuser-Busch INBEV SA/NV
SVRN0.95N/A
+0.23%
OceanPal Inc.
SPOK13.48-0.17
-1.25%
Spok Holdings
NVCR11.84-0.35
-2.87%
NovoCure Limited